Rochester Cardiopulmonary Group — Rochester, New York

Rochester Cardiopulmonary Group is a clinical research site located in Rochester, New York, United States 14621.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Rochester Cardiopulmonary Group has participated in 2 clinical trials.

Therapeutic areas: Chronic Total Occlusion of Coronary Artery, Vascular Disease, Myocardial Ischemia.

Sponsors: Abbott Medical Devices, Forest Laboratories.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester Cardiopulmonary Group?

Rochester Cardiopulmonary Group has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester Cardiopulmonary Group conducted?

Rochester Cardiopulmonary Group has 2 clinical trials on record. Their work covers Chronic Total Occlusion of Coronary Artery, Vascular Disease, Myocardial Ischemia.

Is Rochester Cardiopulmonary Group accredited by Crixeo Health?

Rochester Cardiopulmonary Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester Cardiopulmonary Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.